Clinical Trials
2 trialsNCT04846452 2021-08-12
Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04942301 2021-06-30
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown